Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment

by Business Wire • 2023/04/05 • 0 Comments

DALLAS--(BUSINESS WIRE)--Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment

← Exegenesis Bio To Present Five Posters at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, Los Angeles, CA, May 16-20, 2023

Mojo Vision Raises $22.4M in First Close of New Series A Round for Development of High Performance Micro-LED Technology →